TY - JOUR T1 - [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]. A1 - Imamura,Masayuki, PY - 2005/8/27/pubmed PY - 2005/10/1/medline PY - 2005/8/27/entrez SP - 472 EP - 8 JF - Nihon Geka Gakkai zasshi JO - Nihon Geka Gakkai Zasshi VL - 106 IS - 8 N2 - Recent strategies for the treatment of pancreatic endocrine tumors are described. Most cases are metastatic, and liver metastasis is the most significant prognostic factor. Thus curative resection before liver metastasis develops based on the localization of the tumors with the SASI test is the standard strategy. Subtotal distal pancreatectomy or pancreas-preserving total duodenectomy is indicated for multiple pancreatic endocrine tumors and multiple duodenal gastrinomas, respectively, for patients with multiple endocrine neoplasia type 1. SN - 0301-4894 UR - https://www.unboundmedicine.com/medline/citation/16119110/[Treatment_for_pancreatic_endocrine_tumors_with_or_without_multiple_endocrine_neoplasia_type_1]_ L2 - http://www.diseaseinfosearch.org/result/4954 DB - PRIME DP - Unbound Medicine ER -